SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Sinovac Biotech Ltd. & Encourages Investors with Losses to Con...
24 December 2016 - 7:08AM
Business Wire
Lundin Law PC, a shareholder rights firm, announces that it is
investigating claims against Sinovac Biotech Ltd. (“Sinovac” or the
“Company”) (Nasdaq: SVA) concerning possible violations of federal
securities laws.
To get more information about this investigation, please contact
Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or via
email at brian@lundinlawpc.com.
On December 21, 2016, SeekingAlpha.com released an article
stating that according to a recent Beijing court judgment, Weidong
Ying, Chairman and CEO of Sinovac, paid bribes to Yin Hongzhang,
the Deputy Director General of the Center for Drug Evaluation for
the China Food and Drug Administration, as well as his wife, with
the intention of assisting its vaccine clinical trial and
approval.
Lundin Law PC was founded by Brian Lundin, a securities
litigator based in Los Angeles dedicated to upholding shareholders’
rights.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161223005340/en/
Lundin Law PCBrian Lundin, Esq.Telephone: 888-713-1033Facsimile:
888-713-1125brian@lundinlawpc.comhttp://lundinlawpc.com/
Sinovac Biotech (NASDAQ:SVA)
Historical Stock Chart
From Apr 2024 to May 2024
Sinovac Biotech (NASDAQ:SVA)
Historical Stock Chart
From May 2023 to May 2024